Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15  months. Recent molecular characterization studies...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Mahmoud S. Alghamri, Brandon L. McClellan, Carson S. Hartlage, Santiago Haase, Syed Mohd Faisal, Rohit Thalla, Ali Dabaja, Kaushik Banerjee, Stephen V. Carney, Anzar A. Mujeeb, Michael R. Olin, James J. Moon, Anna Schwendeman, Pedro R. Lowenstein, Maria G. Castro
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Frontiers Media S.A. 2021-05-01
Saila:Frontiers in Pharmacology
Gaiak:
Sarrera elektronikoa:https://www.frontiersin.org/articles/10.3389/fphar.2021.680021/full

Antzeko izenburuak